129 related articles for article (PubMed ID: 28289664)
1. Significance of micrometastases in the calculation of the lymph node ratio for papillary thyroid cancer.
Chang YW; Kim HS; Jung SP; Kim HY; Lee JB; Bae JW; Son GS
Ann Surg Treat Res; 2017 Mar; 92(3):117-122. PubMed ID: 28289664
[TBL] [Abstract][Full Text] [Related]
2. Pre-ablation stimulated thyroglobulin is a better predictor of recurrence in pathological N1a papillary thyroid carcinoma than the lymph node ratio.
Chang YW; Kim HS; Jung SP; Kim HY; Lee JB; Bae JW; Son GS
Int J Clin Oncol; 2016 Oct; 21(5):862-868. PubMed ID: 26837274
[TBL] [Abstract][Full Text] [Related]
3. Number of Metastatic Lymph Nodes and Ratio of Metastatic Lymph Nodes to Total Number of Retrieved Lymph Nodes Are Risk Factors for Recurrence in Patients With Clinically Node Negative Papillary Thyroid Carcinoma.
Zheng CM; Ji YB; Song CM; Ge MH; Tae K
Clin Exp Otorhinolaryngol; 2018 Mar; 11(1):58-64. PubMed ID: 29032663
[TBL] [Abstract][Full Text] [Related]
4. Lymph node ratio predicts recurrence in pediatric papillary thyroid cancer.
Rubinstein JC; Dinauer C; Herrick-Reynolds K; Morotti R; Callender GG; Christison-Lagay ER
J Pediatr Surg; 2019 Jan; 54(1):129-132. PubMed ID: 30361076
[TBL] [Abstract][Full Text] [Related]
5. Lymph node ratio of the central compartment is a significant predictor for locoregional recurrence after prophylactic central neck dissection in patients with thyroid papillary carcinoma.
Ryu IS; Song CI; Choi SH; Roh JL; Nam SY; Kim SY
Ann Surg Oncol; 2014 Jan; 21(1):277-83. PubMed ID: 24006096
[TBL] [Abstract][Full Text] [Related]
6. Combined role of lymph node ratio and serum thyroglobulin levels in predicting prognosis of papillary thyroid carcinoma.
Jeon S; Kwon SY; Ryu YJ; Kang SR; Yoo SW; Cho SG; Kim J; Song HC; Sohn SJ; Bom HS; Min JJ
Nucl Med Commun; 2020 Aug; 41(8):733-739. PubMed ID: 32427697
[TBL] [Abstract][Full Text] [Related]
7. Central Lymph Node Ratio Predicts Recurrence in Patients with N1b Papillary Thyroid Carcinoma.
Kang IK; Kim K; Park J; Bae JS; Kim JS
Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35954338
[TBL] [Abstract][Full Text] [Related]
8. Lymph Node Ratio Predicts Recurrence in Patients with Papillary Thyroid Carcinoma with Low Lymph Node Yield.
Kang IK; Park J; Bae JS; Kim JS; Kim K
Cancers (Basel); 2023 May; 15(11):. PubMed ID: 37296909
[TBL] [Abstract][Full Text] [Related]
9. The Clinical Significance of Lymph Node Ratio and Ki-67 Expression in Papillary Thyroid Cancer.
Lindfors H; Ihre Lundgren C; Zedenius J; Juhlin CC; Shabo I
World J Surg; 2021 Jul; 45(7):2155-2164. PubMed ID: 33825961
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of lymph node ratio in children and adolescents with papillary thyroid cancer.
Xu Y; Wang Y; Zhang X; Huang R; Tian R; Liu B
Clin Endocrinol (Oxf); 2021 Oct; 95(4):649-656. PubMed ID: 33914928
[TBL] [Abstract][Full Text] [Related]
11. Predictive Value of the Number of Harvested Lymph Nodes and Cut-Off for Lymph Node Ratio in the Prognosis of Stage II and III Colorectal Cancer Patients.
Li Destri G; Barchitta M; Pesce A; Latteri S; Bosco D; Di Cataldo A; Agodi A; Puleo S
J Invest Surg; 2019 Jan; 32(1):1-7. PubMed ID: 28972442
[TBL] [Abstract][Full Text] [Related]
12. Prognostic implications of lymph node yield and lymph node ratio in papillary thyroid carcinoma.
Vas Nunes JH; Clark JR; Gao K; Chua E; Campbell P; Niles N; Gargya A; Elliott MS
Thyroid; 2013 Jul; 23(7):811-6. PubMed ID: 23373961
[TBL] [Abstract][Full Text] [Related]
13. Impact factors for the outcome of the first
Shangguan L; Fang S; Zhang P; Han S; Shen X; Geng Y; Luo D; Zhao C
Ann Nucl Med; 2019 Mar; 33(3):177-183. PubMed ID: 30515649
[TBL] [Abstract][Full Text] [Related]
14. The stratification of patient risk depending on the size and ratio of metastatic lymph nodes in papillary thyroid carcinoma.
Hong YR; Lee SH; Lim DJ; Kim MH; Jung CK; Chae BJ; Song BJ; Bae JS
World J Surg Oncol; 2017 Apr; 15(1):74. PubMed ID: 28376807
[TBL] [Abstract][Full Text] [Related]
15. Preablative Stimulated Thyroglobulin Levels Can Predict Malignant Potential and Therapeutic Responsiveness of Subcentimeter-Sized, 18F-fluorodeoxyglucose-Avid Cervical Lymph Nodes in Patients With Papillary Thyroid Cancer.
Kwon SY; Kim J; Jung SH; Chong A; Song HC; Bom HS; Min JJ
Clin Nucl Med; 2016 Jan; 41(1):e32-8. PubMed ID: 26164179
[TBL] [Abstract][Full Text] [Related]
16. Association of Lymph Node Status With Survival in Patients After Liver Resection for Hilar Cholangiocarcinoma in an Italian Multicenter Analysis.
Giuliante F; Ardito F; Guglielmi A; Aldrighetti L; Ferrero A; Calise F; Giulini SM; Jovine E; Breccia C; De Rose AM; Pinna AD; Nuzzo G
JAMA Surg; 2016 Oct; 151(10):916-922. PubMed ID: 27556741
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of the metastatic lymph node ratio and maximal metastatic tumor size in pathological N1a papillary thyroid carcinoma.
Jeon MJ; Yoon JH; Han JM; Yim JH; Hong SJ; Song DE; Ryu JS; Kim TY; Shong YK; Kim WB
Eur J Endocrinol; 2013 Feb; 168(2):219-25. PubMed ID: 23161752
[TBL] [Abstract][Full Text] [Related]
18. Lymph Node Ratio as an Alternative to the Number of Metastatic Lymph Nodes for the Prediction of Esophageal Carcinoma Patient Survival.
Wei C; Deng WY; Li N; Shen W; Zhang C; Liu JY; Luo SX
Dig Dis Sci; 2015 Sep; 60(9):2771-6. PubMed ID: 25939544
[TBL] [Abstract][Full Text] [Related]
19. The clinicopathologic differences of central lymph node metastasis in predicting lateral lymph node metastasis and prognosis in papillary thyroid cancer associated with or without Hashimoto's thyroiditis.
Zhu Y; Zheng K; Zhang H; Chen L; Xue J; Ding M; Wu K; Wang Z; Kong L; Chen X
Tumour Biol; 2016 Jun; 37(6):8037-45. PubMed ID: 26711787
[TBL] [Abstract][Full Text] [Related]
20. Revisiting the concept of lymph node metastases of pancreatic head cancer: number of metastatic lymph nodes and lymph node ratio according to N stage.
Kang MJ; Jang JY; Chang YR; Kwon W; Jung W; Kim SW
Ann Surg Oncol; 2014 May; 21(5):1545-51. PubMed ID: 24419758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
